characteristics.text: SAMN20338873
characteristics.characteristic: External Id
characteristics.text: Hong Kong University
characteristics.characteristic: INSDC center name
characteristics.text: 2024-07-18T00:50:21.570Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-07-18T00:50:21.570Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS9553341
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS9553341
characteristics.characteristic: SRA accession
characteristics.text: 52 years
characteristics.characteristic: age
characteristics.text: Department of Medicine, Hong Kong University; Room 311, Professorial Block, Queen Mary Hospital, Pokfulam, Hong Kong
characteristics.characteristic: biomaterial_provider
characteristics.text: Myelodysplastic syndrome (MDS)
characteristics.characteristic: disease
characteristics.text: Post FLT3, BCL2 inhibitor and hypomethylating agent
characteristics.characteristic: disease_stage
characteristics.text: Asian
characteristics.characteristic: ethnicity
characteristics.text: transformed accute myeloid leukemia
characteristics.characteristic: health_state
characteristics.text: myelodysplastic patient
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Bone marrow mononuclear cell
characteristics.characteristic: sample_type
characteristics.text: male
characteristics.characteristic: sex
characteristics.text: bone marrow
characteristics.characteristic: tissue
characteristics.text: Patient 1 post Midostaurin , Veneotclax and Decitabine
characteristics.characteristic: title
characteristics.text: Midostaurin , Veneotclax and Decitabine
characteristics.characteristic: treatment